Cancer-related fatigue (CrF) is increasingly recognized as a signi cant problem for patients with cancer at all stages, including those undergoing therapy and in remission. In fact, studies have shown that CrF causes patients more distress than pain, nausea, or vomiting and yet fatigue is still often undertreated and rarely studied. However, several new treatments such as are being investigated to determine the most effective ways to manage this debilitating symptom and improve patient quality of life. Cancer-Related Fatigue will provide a concise overview of this condition, with an evidence-based discussion of diagnosis, treatment, and long-term management.
Autorentext
Dr Markus Horneber, Department of Oncology/Hematology, Klinikum Nuernberg, Germany.
Dr Joachim Weis, Tumor Biology Centre, University of Freiburg, Germany.
Zusammenfassung
Cancer-related fatigue (CrF) is increasingly recognized as a signicant problem for patients with cancer at all stages, including those undergoing therapy and in remission. In fact, studies have shown that CrF causes patients more distress than pain, nausea, or vomiting and yet fatigue is still often undertreated and rarely studied. However, several new treatments such as are being investigated to determine the most effective ways to manage this debilitating symptom and improve patient quality of life. Cancer-Related Fatigue will provide a concise overview of this condition, with an evidence-based discussion of diagnosis, treatment, and long-term management.
Inhalt
Introduction.- Etiology and pathogenetic factors.- Nonpharmacological treatment of cancer-related fatigue.- Pharmacological treatment of cancer-related fatigue.- Recommendations for the management of cancer-related fatigue.